Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of fenfluramine hydrochloride in Rett syndrome
CTR20262430Phase 3Active
- Sponsor
- UCB
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenfluramine in Rett syndrome (RTT), sponsored by UCB. Started Jun 2026; status: active.
02
Drugs
fenfluramine
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on CTR20262430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262430.